Improving Neoantigen DNA Vaccines for Optimal Anti-Tumor T Cell Immunity

Time: 12:00 pm
day: Track B - Day 1 AM

Details:

• Discussing the importance of MHC class II restricted neoantigens
• PyroVant: a novel pyroptotic adjuvant
• AmpliVax: a method to produce synthetic DNA vaccines
• Optimisation of intradermal vaccine delivery

Speakers: